Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4356816
[patent_doc_number] => 06255071
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Mammalian viral vectors and their uses'
[patent_app_type] => 1
[patent_app_number] => 8/820931
[patent_app_country] => US
[patent_app_date] => 1997-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 26799
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255071.pdf
[firstpage_image] =>[orig_patent_app_number] => 820931
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/820931 | Mammalian viral vectors and their uses | Mar 18, 1997 | Issued |
08/813771 | NEW APPLICATIONS OF GENE THERAPY TECHNOLOGY | Mar 6, 1997 | Abandoned |
Array
(
[id] => 3808799
[patent_doc_number] => 05831069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Antisense oligonucleotides against nonstructural proteins NS1 and NS2 of respiratory syncytial virus and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/811322
[patent_app_country] => US
[patent_app_date] => 1997-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7526
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/831/05831069.pdf
[firstpage_image] =>[orig_patent_app_number] => 811322
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/811322 | Antisense oligonucleotides against nonstructural proteins NS1 and NS2 of respiratory syncytial virus and uses thereof | Mar 3, 1997 | Issued |
Array
(
[id] => 4002861
[patent_doc_number] => 05858990
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Fas ligand compositions for treatment of proliferative disorders'
[patent_app_type] => 1
[patent_app_number] => 8/810453
[patent_app_country] => US
[patent_app_date] => 1997-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28430
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858990.pdf
[firstpage_image] =>[orig_patent_app_number] => 810453
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/810453 | Fas ligand compositions for treatment of proliferative disorders | Mar 3, 1997 | Issued |
08/807500 | NUCLEOTIDE SEQUENCE FOR TREATING CANCER AND INFECTION | Feb 26, 1997 | Abandoned |
Array
(
[id] => 4098863
[patent_doc_number] => 06096880
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Circular DNA vectors for synthesis of RNA and DNA'
[patent_app_type] => 1
[patent_app_number] => 8/805631
[patent_app_country] => US
[patent_app_date] => 1997-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 24718
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096880.pdf
[firstpage_image] =>[orig_patent_app_number] => 805631
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/805631 | Circular DNA vectors for synthesis of RNA and DNA | Feb 25, 1997 | Issued |
Array
(
[id] => 3773224
[patent_doc_number] => 05849903
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Antisense oligonucleotides for IL-8 and IL-8 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/796031
[patent_app_country] => US
[patent_app_date] => 1997-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4374
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849903.pdf
[firstpage_image] =>[orig_patent_app_number] => 796031
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/796031 | Antisense oligonucleotides for IL-8 and IL-8 receptor | Feb 4, 1997 | Issued |
Array
(
[id] => 4028482
[patent_doc_number] => 05994124
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Ribozyme-snRNA chimeric molecules having a catalytic activity for nuclear RNAs'
[patent_app_type] => 1
[patent_app_number] => 8/781620
[patent_app_country] => US
[patent_app_date] => 1997-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 5080
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994124.pdf
[firstpage_image] =>[orig_patent_app_number] => 781620
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/781620 | Ribozyme-snRNA chimeric molecules having a catalytic activity for nuclear RNAs | Jan 8, 1997 | Issued |
08/773302 | ANTIMICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON UNIQUE APICOMPLEXAN PARASITE METABOLIC PATHWAYS ENZYMES, AND NUCLEIC ACIDS | Dec 22, 1996 | Abandoned |
Array
(
[id] => 3785130
[patent_doc_number] => 05840556
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Molecular genetic construction of vaccine strains of pasteurellaceae'
[patent_app_type] => 1
[patent_app_number] => 8/770234
[patent_app_country] => US
[patent_app_date] => 1996-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7151
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840556.pdf
[firstpage_image] =>[orig_patent_app_number] => 770234
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/770234 | Molecular genetic construction of vaccine strains of pasteurellaceae | Dec 18, 1996 | Issued |
Array
(
[id] => 4129465
[patent_doc_number] => 06120993
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => '5-oxoprolinase'
[patent_app_type] => 1
[patent_app_number] => 8/762428
[patent_app_country] => US
[patent_app_date] => 1996-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15539
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/120/06120993.pdf
[firstpage_image] =>[orig_patent_app_number] => 762428
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/762428 | 5-oxoprolinase | Dec 8, 1996 | Issued |
Array
(
[id] => 4355383
[patent_doc_number] => 06174669
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Method for making full-length cDNA libraries'
[patent_app_type] => 1
[patent_app_number] => 8/752540
[patent_app_country] => US
[patent_app_date] => 1996-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4470
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174669.pdf
[firstpage_image] =>[orig_patent_app_number] => 752540
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752540 | Method for making full-length cDNA libraries | Nov 19, 1996 | Issued |
Array
(
[id] => 3871040
[patent_doc_number] => 05837819
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'TAB1 protein'
[patent_app_type] => 1
[patent_app_number] => 8/752891
[patent_app_country] => US
[patent_app_date] => 1996-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 7017
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837819.pdf
[firstpage_image] =>[orig_patent_app_number] => 752891
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752891 | TAB1 protein | Nov 19, 1996 | Issued |
Array
(
[id] => 4231247
[patent_doc_number] => 06117633
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-12
[patent_title] => 'DNA sequence encoding the tumor suppressor gene ING1'
[patent_app_type] => 1
[patent_app_number] => 8/751230
[patent_app_country] => US
[patent_app_date] => 1996-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 17367
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/117/06117633.pdf
[firstpage_image] =>[orig_patent_app_number] => 751230
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/751230 | DNA sequence encoding the tumor suppressor gene ING1 | Nov 14, 1996 | Issued |
Array
(
[id] => 3969276
[patent_doc_number] => 05886166
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector'
[patent_app_type] => 1
[patent_app_number] => 8/749495
[patent_app_country] => US
[patent_app_date] => 1996-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 7721
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/886/05886166.pdf
[firstpage_image] =>[orig_patent_app_number] => 749495
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/749495 | Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector | Nov 14, 1996 | Issued |
Array
(
[id] => 3801032
[patent_doc_number] => 05853764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Process for preparing fine powder of silk fibroin'
[patent_app_type] => 1
[patent_app_number] => 8/702451
[patent_app_country] => US
[patent_app_date] => 1996-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2175
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/853/05853764.pdf
[firstpage_image] =>[orig_patent_app_number] => 702451
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/702451 | Process for preparing fine powder of silk fibroin | Sep 25, 1996 | Issued |
08/719381 | NOVEL MICROORGANISMS WITH ABILITY TO DEGRADE INDOLE AND NOVEL ENZYMES THEREFROM | Sep 24, 1996 | Abandoned |
Array
(
[id] => 4084000
[patent_doc_number] => 06025192
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Modified retroviral vectors'
[patent_app_type] => 1
[patent_app_number] => 8/716926
[patent_app_country] => US
[patent_app_date] => 1996-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18301
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025192.pdf
[firstpage_image] =>[orig_patent_app_number] => 716926
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/716926 | Modified retroviral vectors | Sep 19, 1996 | Issued |
Array
(
[id] => 1364894
[patent_doc_number] => 06566054
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Cyclin dependent kinase mutants, and diagnostic and therapeutic uses related thereto'
[patent_app_type] => B1
[patent_app_number] => 08/706322
[patent_app_country] => US
[patent_app_date] => 1996-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 24307
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566054.pdf
[firstpage_image] =>[orig_patent_app_number] => 08706322
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/706322 | Cyclin dependent kinase mutants, and diagnostic and therapeutic uses related thereto | Aug 29, 1996 | Issued |
Array
(
[id] => 1423713
[patent_doc_number] => 06503752
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Lymphotropic agents and vectors'
[patent_app_type] => B1
[patent_app_number] => 08/646242
[patent_app_country] => US
[patent_app_date] => 1996-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 16
[patent_no_of_words] => 8758
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503752.pdf
[firstpage_image] =>[orig_patent_app_number] => 08646242
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/646242 | Lymphotropic agents and vectors | Jul 22, 1996 | Issued |